Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Private equity firm jumps into vascular health with new investment
Vascular Technology, first founded 40 years ago, is planning on using the new funds to grow and expand its portfolio.
At a crossroads: Surgical heart valve innovation slows as transcatheter treatments keep evolving
Has the success of TAVR and other interventional techniques had a negative impact on surgical valve innovation? Two surgeons shared their concerns in a new commentary.
What can federal health agencies do to revive the fading trust of the public?
Confidence in public health entities is spiraling downward in the U.S., and once-revered Washington institutions like the CDC and NIH are among the casualties in serious condition. How to break the negative momentum?
Polymer heart valve, the first of its kind to gain commercial approval, linked to positive 1-year data
The new-look mitral valve is built using LifePolymer, a proprietary material that does not include any animal tissue. Both the frame and its leaflets are robotically generated to match each patient’s anatomy.
AAP, other physician societies double down on Kennedy-crossing vaccination stance
5 high-profile physician leaders: ‘Misinformation, politicization of commonsense public health efforts and sudden changes to federal vaccine guidance are creating mass confusion and diminishing trust in public health.’

Reducing CIED Infections and the Cost of Care: Lessons from Cleveland Clinic

Sponsored by Medtronic

Thinking has changed: Cardiac implantable electronic device (CIED) infections are a bigger deal than we thought.

non-small cell lung cancer tumor segmentation

Algorithm reduces NSCLC tumor segmentation times by 65%

In a close collaboration with radiation oncologists, experts trained their model on the CT lung images of 787 patients and tested it on the scans of more than 1,300 patients from external datasets.

Onyx Frontier drug-eluting stent Medtronic FDA approval CE mark approval

Medtronic launches updated drug-eluting coronary stent system

The news comes after the Onyx Frontier DES gained CE mark approval. It received FDA approval in May.

Myocarditis risk higher after COVID-19 infection than after vaccination, new study of 43 million patients confirms

The new analysis, published in Circulation, confirmed that vaccine-related myocarditis is incredibly rare.

5 imaging modalities have changed the war on cancer over the past 50 years. How many can you name?

Two branch chiefs with the cancer imaging program at NIH’s National Cancer Institute have produced a written commemoration to mark the golden anniversary of 1971’s National Cancer Act.

NSAID use may not be safe for older patients with type 2 diabetes

The new analysis, based on data from more than 330,000 patients, is scheduled to be presented during ESC Congress 2022.

Cancer patients who undergo PCI face a higher risk of early mortality

Overall, PCI patients appear to face a higher risk of in-hospital mortality, 30-day mortality and in-hospital cardiovascular mortality if they present with an active or historical cancer diagnosis. The group's analysis included data from nearly 6.6 million patients.

Jianyi "Jay" Zhang, MD, PhD, is leading research on growing new heart muscle cells

Researchers receive $11.2M to study how the heart recovers from significant damage

The National Heart, Lung and Blood Institute, part of the National Institutes of Health, awarded the funds to three research teams.

Clinical

Private equity firm jumps into vascular health with new investment

At a crossroads: Surgical heart valve innovation slows as transcatheter treatments keep evolving

What can federal health agencies do to revive the fading trust of the public?

Polymer heart valve, the first of its kind to gain commercial approval, linked to positive 1-year data

AAP, other physician societies double down on Kennedy-crossing vaccination stance